<DOC>
	<DOCNO>NCT01891708</DOCNO>
	<brief_summary>a. VEGFRs may biomarker predict effect bevacizumab non small cell lung cancer</brief_summary>
	<brief_title>VEGFRs Predict Bevacizumab Benefit Advanced Non Small Cell Lung Cancer</brief_title>
	<detailed_description>1. non small cell lung cancer ( non squamous carcinoma ) 2 . ECOG 0-1 3. 18-75 year old</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>non squamous cell non small cell lung cancer measurable disease ECOG 01 patient receive surgery recent 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>